BioCryst Pharmaceuticals financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

바이오크리스트 파머슈티컬스NASDAQ:BCRX · Nasdaq · Healthcare · sector #17

$7.95-1.85%

2026-10-06 close

BioCryst Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $451M. 2024 operating profit was −$3M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy